Developed by a team at Otoharmonics® Corporation, based in Portland, Oregon, USA, with technology originally developed at Cedars-Sinai, the Levo System uses sound therapy to train the brain to ignore ringing sounds caused by tinnitus. Levo is designed to be user-friendly and capable of delivering custom sound therapy based on the specific needs of the individual.
Otoharmonics engaged StarFish Medical to help with a number of challenges: PHI (Personal Health Information) constraints, iPad and iPods as medical device components, sound output risks, patient-specific custom ear buds, software maintenance, and FDA regulatory submission assistance.
The Levo System is the first Apple hardware Class II device cleared by the FDA. Otoharmonics received FDA 510(k) clearance for an iPad and iPod Touch application that treats tinnitus. The Levo System medical device provides patients a patented personal sound therapy which through neural habituation leverages the cognitive abilities of the brain to reduce the symptoms of their tinnitus and improve the quality of a patient’s daily life.
The Levo System was awarded the top prize in the Digital Health Products and Mobile Medical Apps category of the 19th Annual Medical Design Excellence Awards competition.
Client: Levo Medical Corporation, Otoharmonics